signalgroup

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

September 10, 2020 signalgroup

The Biosimilars Forum Filed Comment on FDA’s Notice Detailing the Impact of Disclosure Statements in Biosimilar Promotional Materials

July 31, 2020 signalgroup

ICYMI: Experts Detail How Shared Savings Model for Biosimilars Could Provide Savings for Seniors, Patients and Medicare

July 31, 2020 signalgroup

MedPac: Top 10 Most Expensive Medicare Part B Drugs are Originator Biologics

July 24, 2020 signalgroup

Trump Administration’s Drug Plan Must Include Biosimilars to Lower Costs for Seniors and Medicare

July 14, 2020 signalgroup

ICYMI: House Appropriators Encourage CMS to Support Biosimilars; Experts Point to Biosimilars to Help Lower Drug Costs, Call on Congress and Administration to Act

July 1, 2020 signalgroup

The Biosimilars Forum Applauds Senators Cornyn and Bennet’s Introduction of Legislation to Lower Health Costs by Supporting Biosimilars

June 22, 2020 signalgroup

The Biosimilars Forum To Provide Comment at FDA’s Annual Meeting on the Biosimilar User Fee Program

May 28, 2020 signalgroup

Bringing Down Federal Spending: A Biosimilars Shared Savings Model To Lower Health Care Costs

May 27, 2020 signalgroup

Robust Biosimilars Market Could Save U.S. Taxpayers $7 Billion Annually, New Analysis Finds

May 21, 2020 signalgroup

AMA: U.S. Health Insurance Plans Prefer Brand Biologics Twice as Often as Lower-Cost Biosimilars